acetylcysteine has been researched along with Bone Loss, Perimenopausal in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Li, J; Li, X; Miao, D; Wang, Q; Yang, R; Zhang, J; Zhou, X | 1 |
Kotowicz, MA; Nicholson, GC; Sanders, KM | 1 |
1 trial(s) available for acetylcysteine and Bone Loss, Perimenopausal
Article | Year |
---|---|
Potential role of the antioxidant N-acetylcysteine in slowing bone resorption in early post-menopausal women: a pilot study.
Topics: Acetylcysteine; Administration, Oral; Animals; Antioxidants; Biomarkers; Bone Resorption; Calcium; Cholecalciferol; Collagen Type I; Double-Blind Method; Female; Humans; Mice; Middle Aged; Osteoporosis, Postmenopausal; Peptides; Pilot Projects; Postmenopause | 2007 |
1 other study(ies) available for acetylcysteine and Bone Loss, Perimenopausal
Article | Year |
---|---|
BMI-1 Mediates Estrogen-Deficiency-Induced Bone Loss by Inhibiting Reactive Oxygen Species Accumulation and T Cell Activation.
Topics: Acetylcysteine; Animals; CD4-Positive T-Lymphocytes; Estrogens; Female; Humans; Lymphocyte Activation; Mice; Mice, Transgenic; Osteoporosis, Postmenopausal; Ovariectomy; Polycomb Repressive Complex 1; Proto-Oncogene Proteins; Reactive Oxygen Species; Receptors, Estrogen | 2017 |